The global Genetic Testing Services market is projected to have a considerable CAGR during the forecast period. The growing prevalence of chronic diseases such as cancer, infectious diseases across the globe further contributes to the growth of the genetic testing services market. As per the International Agency for Research on Cancer (IARC), in 2018 there were 17 million new cancer cases and 9.5 million cancer mortality across the globe. Moreover, the global cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer mortality in 2020.
A full report of Genetic Testing Services Market is available at: https://www.omrglobal.com/industry-reports/genetic-testing-services-market
The major reason for increasing chronic disease includes lack of nutritious diet, physical activities, and aging population. The genetic alterations enable in driving development & progress of different types of cancer which are identified through the platform of research studies.
Growing R&D in genomics further boost the genetic testing services market growth
Increasing genomic and proteomic researches Proteomics refers to the analysis of overall proteins present content of a cell, tissue or an organism. It comprises of identi?cation and quanti?cation technologies and also uses technologies such as genomics and transcriptomics. Genomic studies and advanced technologies enable defining driver mutation and alteration of DNA & RNA in many cancers. The genomic information from tumors and normal tissue are compared which helps the required genomic changes. The genomic methods are used to detect molecular characteristics for clinical phenotypes which enables the detection of genetic changes. Increasing investment and research in genomics and proteomics are also significantly driving market growth.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/genetic-testing-services-market
Emerging Markets is likely to contribute significantly to the genetic testing services market
The emerging economies such as the Asia-Pacific region are one of the potential markets for genomic biomarkers. The factors that will be favorable for the growth of the market in this region include increasing government expenditures on healthcare in the region, and the presence of a huge population suffering from various chronic diseases such as cancer, hypertrophic cardiomyopathies, arrhythmias, and others. The average annual increase in government healthcare spending in the US is 4.5% and less than 1.5% in the European Union. However, the countries of Asia-Pacific reported an increase in healthcare expenditure of more than 6%, which is higher than the developed nations.
Moreover, the 1000 Genomes Project is an effort that comprises genome sequencing of at least a thousand people from across the globe to develop the most comprehensive and medically relevant picture of human genetic variation. This initiative intends to make accessible genomic data easily from international research institutions. The major support for the project is offered by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), Wellcome Trust Sanger Institute in Hinxton, England, and the Beijing Genomics Institute, Shenzhen (BGI Shenzhen) in China. Therefore, these genome projects further provide a significant opportunity for market growth in emerging markets.
Global Genetic Testing Services Market Segmentation
- Predictive & Presymptomatic Testing
- Prenatal Testing
- Diagnostic Testing
- Newborn Screening
- Infectious Diseases
- Autoimmune Disease
- Others (Rare Disease)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/genetic-testing-services-market
Global Genetic Testing Services Market – Segment by Region
- United States
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
- 23andMe, Inc.
- Abbott Laboratories
- Ambry Genetics Corp, A Konica Minolta Company
- Blueprint Genetics Oy
- bioMérieux SA
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- deCODE genetics
- Danaher Corp.
- Centogene AG
- Eurofins GSC Lux SARL
- F. Hoffmann-La Roche Ltd.
- GeneDx, Inc.
- Helix OpCo LLC
- Illumina, Inc.
- Luminex Corp.
- Myriad Genetics, Inc.
- NeoGenomics Laboratories, Inc.
- PerkinElmer Inc.
- Quest Diagnostics Inc.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404